“Revolutionizing Wet AMD Treatment: Outlook Therapeutics Unveils Promising Results from NORSE EIGHT Clinical Trial of ONS-5010”
Outlook Therapeutics Announces Data Presentation at Hawaiian Eye and Retina 2025 Meeting ISELIN, N.J., Jan. 23, 2025 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK) A Breakthrough in Wet AMD Treatment Outlook Therapeutics, Inc., a leading biopharmaceutical company, has made waves in the medical community with its recent regulatory approval in the European Union and…